Current Environment: Production

617-355-7800

Department of Surgery | Education

Undergraduate School

Westfield State University

2005, Westfield, MA

Graduate School

Wheelock College

2006, Boston, MA

Department of Surgery | Education

Undergraduate School

Mercer University

Macon, GA

Graduate School

Wheelock College

Boston, MA

Department of Surgery | Education

Undergraduate School

University of Maryland College Park

2005, College Park, MD

Graduate School

Training in Advanced Practice Nursing Institution

Boston College

2013, Chestnut Hill, MA

Internship

Dietetic Internship Institution

University of Connecticut

Storrs, CT

Department of Surgery | Education

Undergraduate School

BS, Nursing

Curry College, School of Nursing

1988, Milton, MA

Graduate School

Pediatric Nurse Practitioner Program

Northeastern University Bouve’ College of Health Sciences

1996, Boston, MA

Department of Surgery | Education

Undergraduate School

Northeastern University

2015, Boston, MA

Graduate School

Simmons University

2020, Boston, MA

Department of Surgery | Education

Undergraduate School

University of Notre Dame

1991, Notre Dame, IN

Medical School

Tulane University School of Medicine

1995 & 2001, New Orleans, LA

Internship

Tulane University School of Medicine

195, New Orleans, LA

Residency

Tulane University School of Medicine

1996, New Orleans, LA

Fellowship

Critical Care

Tulane University

2003, New Orleans, LA

Fellowship

Boston Children's Hospital

2004, Boston, MA

Department of Surgery | Publications

  1. Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. J Natl Cancer Inst. 2024 Oct 01; 116(10):1664-1674. View Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. Abstract

  2. Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery. Cancer Manag Res. 2024; 16:1141-1153. View Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery. Abstract

  3. Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatr Blood Cancer. 2024 Oct; 71(10):e31189. View Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Abstract

  4. Surgical management of liver tumors. Pediatr Blood Cancer. 2025 Apr; 72 Suppl 2:e31155. View Surgical management of liver tumors. Abstract

  5. Correction to: Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatr Radiol. 2024 May; 54(5):862. View Correction to: Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Abstract

  6. Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Pediatr Radiol. 2024 05; 54(5):671-683. View Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. Abstract

  7. Critical elements of pediatric liver cancer surgery. Semin Pediatr Surg. 2023 Oct; 32(5):151340. View Critical elements of pediatric liver cancer surgery. Abstract

  8. A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Cancer Med. 2023 06; 12(12):13300-13308. View A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors. Abstract

  9. Lymphatic Embolization for the Management of Post-operative Chyle Leaks Following Solid Tumor Resection in Pediatric Patients. J Pediatr Surg. 2023 Nov; 58(11):2141-2148. View Lymphatic Embolization for the Management of Post-operative Chyle Leaks Following Solid Tumor Resection in Pediatric Patients. Abstract

  10. Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort. Lancet Oncol. 2023 06; 24(6):691-700. View Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort. Abstract

  11. An aptamer-based depot system for sustained release of small molecule therapeutics. Nat Commun. 2023 04 28; 14(1):2444. View An aptamer-based depot system for sustained release of small molecule therapeutics. Abstract

  12. Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30365. View Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Abstract

  13. Perioperative hypertension and anesthetic management in patients undergoing resection of neuroblastoma. Paediatr Anaesth. 2023 07; 33(7):577-582. View Perioperative hypertension and anesthetic management in patients undergoing resection of neuroblastoma. Abstract

  14. Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2023 05 10; 41(14):2638-2650. View Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study. Abstract

  15. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. J Pediatr Surg. 2022 Oct; 57(10):251-256. View Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. Abstract

  16. Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease. Pediatr Crit Care Med. 2022 09 01; 23(9):e440-e450. View Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease. Abstract

  17. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. Clin Orthop Relat Res. 2023 03 01; 481(3):526-538. View What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. Abstract

  18. 68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Pediatr Blood Cancer. 2022 08; 69(8):e29740. View 68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. Abstract

  19. Complications associated with totally implantable access ports in children less than 1 year of age. J Pediatr Surg. 2022 Oct; 57(10):463-468. View Complications associated with totally implantable access ports in children less than 1 year of age. Abstract

  20. Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer. 2022 03 01; 128(5):1057-1065. View Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Abstract

  21. Interdisciplinary Management of Malignant Ovarian Tumors in the Pediatric and Adolescent Age Group. J Pediatr Adolesc Gynecol. 2022 Jun; 35(3):260-264. View Interdisciplinary Management of Malignant Ovarian Tumors in the Pediatric and Adolescent Age Group. Abstract

  22. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021 09; 155:216-226. View Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Abstract

  23. Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021 06; 68 Suppl 4:e29112. View Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations. Abstract

  24. Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2021 05 04; 113(5):588-596. View Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study. Abstract

  25. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. J Clin Oncol. 2021 08 01; 39(22):2463-2473. View Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol. Abstract

  26. Neonatal Malignant Disorders: Germ Cell Tumors. Clin Perinatol. 2021 03; 48(1):147-165. View Neonatal Malignant Disorders: Germ Cell Tumors. Abstract

  27. Management of Adrenal Tumors in Pediatric Patients. Surg Oncol Clin N Am. 2021 04; 30(2):275-290. View Management of Adrenal Tumors in Pediatric Patients. Abstract

  28. Epidemiology of abdominal wall and groin hernia repairs in children. Pediatr Surg Int. 2021 May; 37(5):587-595. View Epidemiology of abdominal wall and groin hernia repairs in children. Abstract

  29. Opioid Prescription Patterns for Children Following Laparoscopic Appendectomy. Ann Surg. 2020 12; 272(6):1149-1157. View Opioid Prescription Patterns for Children Following Laparoscopic Appendectomy. Abstract

  30. Training in pediatric surgical critical care. Curr Opin Pediatr. 2020 10; 32(5):694-697. View Training in pediatric surgical critical care. Abstract

  31. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Abstract

  32. Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use. Pediatr Blood Cancer. 2020 09; 67(9):e28326. View Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research use. Abstract

  33. Imaging features of pathologically proven pediatric splenic masses. Pediatr Radiol. 2020 08; 50(9):1284-1292. View Imaging features of pathologically proven pediatric splenic masses. Abstract

  34. Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Eur J Cancer. 2020 07; 133:4-13. View Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Abstract

  35. Comparison of Military Health System Data Repository and American College of Surgeons National Surgical Quality Improvement Program-Pediatric. BMC Pediatr. 2019 11 08; 19(1):419. View Comparison of Military Health System Data Repository and American College of Surgeons National Surgical Quality Improvement Program-Pediatric. Abstract

  36. Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer. 2019 11 01; 125(21):3873-3881. View Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Abstract

  37. Therapeutic Impact and Complications Associated with Surgical Lung Biopsy after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant. 2019 11; 25(11):2181-2185. View Therapeutic Impact and Complications Associated with Surgical Lung Biopsy after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Abstract

  38. Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. J Pediatr Surg. 2020 Apr; 55(4):655-659. View Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. Abstract

  39. Geographic distance to pediatric surgical care within the continental United States. J Pediatr Surg. 2019 Jun; 54(6):1112-1117. View Geographic distance to pediatric surgical care within the continental United States. Abstract

  40. Multicenter pre-operative assessment of pediatric ovarian malignancy. J Pediatr Surg. 2019 Sep; 54(9):1921-1925. View Multicenter pre-operative assessment of pediatric ovarian malignancy. Abstract

  41. Clinical features and outcomes of spitzoid proliferations in children and adolescents. Br J Dermatol. 2019 08; 181(2):366-372. View Clinical features and outcomes of spitzoid proliferations in children and adolescents. Abstract

  42. Time versus treatment: interpreting longitudinal data analysis of treprostinil. J Pediatr. 2019 03; 206:304-305. View Time versus treatment: interpreting longitudinal data analysis of treprostinil. Abstract

  43. Nanoscale Bupivacaine Formulations To Enhance the Duration and Safety of Intravenous Regional Anesthesia. ACS Nano. 2019 01 22; 13(1):18-25. View Nanoscale Bupivacaine Formulations To Enhance the Duration and Safety of Intravenous Regional Anesthesia. Abstract

  44. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2018 12; 19(12):1590-1601. View Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Abstract

  45. Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 Sep 14; JCO2018784595. View Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Abstract

  46. Another point of view on 2017 PRETEXT: reply to Pariente et al. Pediatr Radiol. 2018 11; 48(12):1820-1822. View Another point of view on 2017 PRETEXT: reply to Pariente et al. Abstract

  47. Incidence and risk factors for sepsis after childhood splenectomy. J Pediatr Surg. 2019 Jul; 54(7):1445-1448. View Incidence and risk factors for sepsis after childhood splenectomy. Abstract

  48. Pediatric pancreatic neoplasms: The time is nigh for collaboration across continents. Pediatr Blood Cancer. 2018 Oct; 65(10):e27264. View Pediatric pancreatic neoplasms: The time is nigh for collaboration across continents. Abstract

  49. Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018 06 01; 36(16):1571-1578. View Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Abstract

  50. Testicular atrophy following inguinal hernia repair in children. Pediatr Surg Int. 2018 May; 34(5):553-560. View Testicular atrophy following inguinal hernia repair in children. Abstract

  51. Hernia recurrence following inguinal hernia repair in children. J Pediatr Surg. 2018 Nov; 53(11):2214-2218. View Hernia recurrence following inguinal hernia repair in children. Abstract

  52. 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol. 2018 04; 48(4):536-554. View 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Abstract

  53. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol. 2017 Oct 20; 35(30):3465-3473. View Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. Abstract

  54. The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review. Pediatr Surg Int. 2017 Jun; 33(6):683-694. View The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review. Abstract

  55. Malignant glomus tumors of the head and neck in children and adults: Evaluation and management. Laryngoscope. 2017 12; 127(12):2873-2882. View Malignant glomus tumors of the head and neck in children and adults: Evaluation and management. Abstract

  56. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. J Clin Oncol. 2017 Feb 10; 35(5):523-528. View Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. Abstract

  57. Pediatric/"Wildtype" gastrointestinal stromal tumors. Semin Pediatr Surg. 2016 Oct; 25(5):305-310. View Pediatric/"Wildtype" gastrointestinal stromal tumors. Abstract

  58. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895. View Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. Abstract

  59. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Pediatr Transplant. 2016 Aug; 20(5):687-91. View Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Abstract

  60. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016 Jul 01; 2(7):922-8. View Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. Abstract

  61. Preoperative risk stratification of children with ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1507-12. View Preoperative risk stratification of children with ovarian tumors. Abstract

  62. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7. View Poor adherence to staging guidelines for children with malignant ovarian tumors. Abstract

  63. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):401-408. View Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Abstract

  64. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Sep 10; 33(26):2893-900. View Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Abstract

  65. Analysis of submitted abstracts for the American Academy of Pediatrics, Section on Surgery, National Conference (AAP SoSU). J Pediatr Surg. 2015 Jun; 50(6):1058-61. View Analysis of submitted abstracts for the American Academy of Pediatrics, Section on Surgery, National Conference (AAP SoSU). Abstract

  66. Sedation and analgesia in the ICU. Semin Pediatr Surg. 2015 Feb; 24(1):37-46. View Sedation and analgesia in the ICU. Abstract

  67. Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2014 Dec; 18(8):875-81. View Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation. Abstract

  68. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80. View Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. Abstract

  69. Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. J Pediatr Surg. 2013 Jun; 48(6):1269-76. View Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. Abstract

  70. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):334-8. View Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. Abstract

  71. Fetal and neonatal germ cell tumors. Semin Fetal Neonatal Med. 2012 Aug; 17(4):222-230. View Fetal and neonatal germ cell tumors. Abstract

  72. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J Steroid Biochem Mol Biol. 2012 Oct; 132(1-2):186-93. View Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. Abstract

  73. Electrospun drug-eluting sutures for local anesthesia. J Control Release. 2012 Aug 10; 161(3):903-9. View Electrospun drug-eluting sutures for local anesthesia. Abstract

  74. Pediatric gastrointestinal stromal tumor. Semin Pediatr Surg. 2012 Feb; 21(1):31-43. View Pediatric gastrointestinal stromal tumor. Abstract

  75. Adrenal cortical tumors in children: factors associated with poor outcome. J Pediatr Surg. 2011 Jun; 46(6):1201-7. View Adrenal cortical tumors in children: factors associated with poor outcome. Abstract

  76. Facilitators of quality breast cancer screening and diagnosis in an urban environment. J Clin Oncol. 2011 May 20; 29(15_suppl):e16584. View Facilitators of quality breast cancer screening and diagnosis in an urban environment. Abstract

  77. Oncology Medical Home to address challenges in breast cancer care delivery. J Clin Oncol. 2011 May 20; 29(15_suppl):e16641. View Oncology Medical Home to address challenges in breast cancer care delivery. Abstract

  78. Barriers to implementing primary HER2 FISH testing. J Clin Oncol. 2011 May 20; 29(15_suppl):e16642. View Barriers to implementing primary HER2 FISH testing. Abstract

  79. Prophylactic oophorectomy for patients with breast cancer with BRCA results. J Clin Oncol. 2011 May 20; 29(15_suppl):1533. View Prophylactic oophorectomy for patients with breast cancer with BRCA results. Abstract

  80. BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):626. View BRCA+ test result impact and timing on surgical treatment decisions for patients with breast cancer. Abstract

  81. Preoperative MDCT evaluation of congenital lung anomalies in children: comparison of axial, multiplanar, and 3D images. AJR Am J Roentgenol. 2011 May; 196(5):1040-6. View Preoperative MDCT evaluation of congenital lung anomalies in children: comparison of axial, multiplanar, and 3D images. Abstract

  82. Nanotechnology for surgeons. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun; 3(3):223-8. View Nanotechnology for surgeons. Abstract

  83. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011 Mar; 50(3):146-53. View ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Abstract

  84. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Int J Oncol. 2010 Sep; 37(3):541-50. View Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Abstract

  85. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010 Jun; 45(6):1090-5. View Primary lung tumors in children and adolescents: a 90-year experience. Abstract

  86. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010 May; 64(5):688-90. View Adolescent gynecomastia: not only an obesity issue. Abstract

  87. Childhood pancreatic tumors: a single institution experience. J Pediatr Surg. 2009 Dec; 44(12):2267-72. View Childhood pancreatic tumors: a single institution experience. Abstract

  88. In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. J Pediatr Surg. 2009 Nov; 44(11):e21-4. View In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. Abstract

  89. H-type rectovaginal fistula in a patient with bilateral single ectopic ureters. J Pediatr Surg. 2009 Oct; 44(10):e27-30. View H-type rectovaginal fistula in a patient with bilateral single ectopic ureters. Abstract

  90. Reduced size liver transplantation from a donor supported by a Berlin Heart. Am J Transplant. 2009 Nov; 9(11):2641-3. View Reduced size liver transplantation from a donor supported by a Berlin Heart. Abstract

  91. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009 Jun; 44(6):1072-5; discussion 1075-6. View Mortality of necrotizing enterocolitis expressed by birth weight categories. Abstract

  92. Outcomes after the Ladd procedure in patients with heterotaxy syndrome, congenital heart disease, and intestinal malrotation. J Pediatr Surg. 2009 Jun; 44(6):1089-95; discussion 1095. View Outcomes after the Ladd procedure in patients with heterotaxy syndrome, congenital heart disease, and intestinal malrotation. Abstract

  93. Mesenteric lipoblastoma presenting as a segmental volvulus. J Pediatr Surg. 2009 Feb; 44(2):e25-8. View Mesenteric lipoblastoma presenting as a segmental volvulus. Abstract

  94. Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. J Pediatr Surg. 2009 Feb; 44(2):459-63. View Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. Abstract

  95. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008; 10(6):R105. View Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Abstract

  96. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008 Dec; 43(12):2297-300. View Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. Abstract

  97. A familial case of pleuropulmonary blastoma. Eur J Pediatr Surg. 2008 Jun; 18(3):192-4. View A familial case of pleuropulmonary blastoma. Abstract

  98. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008 Feb; 17(1):17-29. View Pediatric pulmonary tumors: primary and metastatic. Abstract

  99. Pediatric Pulmonary Tumors. Seminars in Pediatric Surgery. 2008; in press..

  100. Congenital Esophageal Disorders. Operative Thoracic Surgery. 2008; in press/submitted..

  101. A Familial Case of Pleuropulmonary Blastoma. European Journal of Pediatric Surgery. 2008; in press..

  102. Surgical Aspects of Pediatric Oncology. Nathan and Oski’s Pediatric Hematology and Oncology. 2008; in press/submitted..

  103. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol. 2006 May; 20(5):971-83. View p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Abstract

  104. P38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein1. Molecular Endocrinology,. 2006; 20(5):971-983..

  105. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Int J Oncol. 2005 Mar; 26(3):763-8. View PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Abstract

  106. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy. 2005; 51 Suppl 1:115-21. View Mechanical and antibacterial bowel preparation in colon and rectal surgery. Abstract

  107. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 2004 Aug; 136(2):346-54. View Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Abstract

  108. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol. 2004 Jun; 24(6):1473-80. View Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Abstract

  109. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004 Mar 15; 85(4):193-8. View Solid and papillary epithelial neoplasm of the pancreas. Abstract

  110. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 2003 Oct; 228(9):995-1003. View Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Abstract

  111. Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest. J Am Coll Surg. 2003 Mar; 196(3):475-81. View Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest. Abstract

  112. Guidelines for withholding or termination of resuscitation in prehospital cardiopulmonary arrest. Journal of American College of Surgeons,. 2003; 196(3):475-81..

  113. Sensitization of Apoptotically Resistant Breast Carcinoma Cells to TNF and TRAIL by Inhibition of P38 Mitogen-Activated Protein Kinase Signaling. Proceedings of the Society of Surgical Oncology. 2003.

  114. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol. 2002 Oct; 9(8):738-44. View Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Abstract

  115. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 2002 Aug; 132(2):293-301. View Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Abstract

  116. ATLS training: a novel approach. Bull Am Coll Surg. 2002 Apr; 87(4):15-9. View ATLS training: a novel approach. Abstract

  117. Identification of mitogen-activated protein kinase kinase 5 (mek5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Basic Science Plenary Session, Proceedings of the Society of University Surgeons. 2002.

  118. Identification of mitogen-activated protein kinase kinase 5 (MEK5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Surgery,. 2002; 132(2):292-301..

  119. Advanced Trauma Life Support Training: A novel approach. Bulletin of the American College of Surgeons,. 2002; 87(4):15-19..

  120. Therapy-induced leukemias and myelodysplastic syndromes following breast cancer treatment. Ann Surgical Oncology. 2002; 9(8):738-744.

  121. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol. 2001 Nov; 78(5):409-18. View Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. Abstract

  122. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug; 130(2):143-50. View NF-kappa B-mediated chemoresistance in breast cancer cells. Abstract

  123. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol. 2001 Jul; 19(1):129-35. View Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Abstract

  124. Esophageal carcinosarcoma. J Gastrointest Surg. 2001 Jul-Aug; 5(4):414-7. View Esophageal carcinosarcoma. Abstract

  125. Oestrogen-mediated suppression of TNF-induced apoptosis in MCF-7 cells:subversion of Bcl-2 by antioestrogens. Journal of Ster Biochemistry Mol Biol.,. 2001; 78(5):409-418..

  126. NF-kappa â-mediated chemoresistance in breast cancer cells. Proceedings of the Society of University Surgeons. 2001.

  127. Pre-hospital DNR Protocol: An idea whose time has arrived. Winner, Clinical Trauma Paper Competition. Louisiana State Committee on Trauma. Resident Paper Competition. 2001.

  128. Esophageal carcinosarcoma. Journal of Gastrointestinal Surgery. 2001; 5(4):414-417..

  129. Identification and analysis of molecular mechanisms of chemoresistance in human breast carcinoma cells. 2001.

  130. Identification of chemoresisstance targets in MCF-7 cells using gene microarray. Proceedings of the Society of Surgical Oncology. 2001.

  131. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000 Jun; 16(6):1179-87. View Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Abstract

  132. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun. 2000 May 10; 271(2):342-5. View PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Abstract

  133. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem. 2000 Mar 31; 275(13):9628-35. View Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. Abstract

  134. Characterization of chemoresistance of MCF-7/ADR breast cancer cells. Proceedings of the Society of University Surgeons, Residents’ Conference. 2000.

  135. Modulation of apoptotic pathways for therapeutic advantage in breast cancer. Proceedings of the American Society for Pharmacology and Experimental Therapeutics. 2000; 14(A1516).

  136. MCF-7/ADR breast cancer cell chemonresistance. Proceedings of the American Association of Cancer Research. 2000.

  137. Modulation of apoptotic pathways for therapeutic advantage: MCF-7 cells as a model system. Proceedings of the 5th Annual Multidisciplinary Symposium on Breast Disease. 2000.

  138. Phosphatidylinositol 3-kinase/Akt mediated regulation of NF-êB signaling events as a mechanism for suppression of TNF-induced apoptosis. Biochemistry Biophysiology Res Commun,. 2000; 271(2):342-345..

  139. Differences in protein kinase C and estrogen receptor á, â expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology,. 2000; 16(6):1179-1187..

  140. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 1998 Nov 01; 58(21):4940-6. View Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Abstract

  141. Phorbol ester and insulin-like growth factor-I suppression of TNF-á-induced apoptosis through a phosphatidylinositol-3-kinase mediated inhibition of ceramide formation and caspase activation. Proceedings of the American Association for Cancer Research special conference on Molecular Mechanisms of Apoptosis Regulation. 1998.

  142. MCF-7 breast cancer cell variants display differences in tumor necrosis factor á-included apoptosis. Proceedings of the Society of University Surgeons, Residents’ Conference. 1998.

  143. Breast Leiomyoma. Journal of Louisiana State Medical Society. 1998; 150(8):367-370..

  144. Differences in susceptibility to tumor necrosis factor- á-induced apoptosis among MCF-7 breast cancer cell variants. Proceedings of the American Association for Cancer Research. 1998.

  145. Cross-talk between phosphatidylinositol-3 kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. Journal of Biology and Chemistry,. 1998; 275(13):9628-9635..

  146. Differences in susceptibility to tumor necrosis factor á-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research,. 1998; 58:4940-4946..

  147. Overlapping and nonoverlapping cortical projections to cortex of the superior temporal sulcus in the rhesus monkey: double anterograde tracer studies. J Comp Neurol. 1996 Jun 24; 370(2):173-90. View Overlapping and nonoverlapping cortical projections to cortex of the superior temporal sulcus in the rhesus monkey: double anterograde tracer studies. Abstract

  148. Parvalbumin staining delineates superior temporal polymodal cortex in Macaca mulatta. Proceedings of the Society of Neuroscience. 1993; (19):972.

  149. Organization of cortical projections to the superior temporal polymodal cortex of the rhesus: double anterograde labeling studies. Proceedings of the Society of Neuroscience. 1992; (18):295.

  150. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 Feb; 97(2):194-203. View Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. Abstract

  151. Preoperative three-dimensional reconstruction of the heart and great vessels in patients with congenital heart disease. Technique and initial results. J Thorac Cardiovasc Surg. 1988 Sep; 96(3):464-73. View Preoperative three-dimensional reconstruction of the heart and great vessels in patients with congenital heart disease. Technique and initial results. Abstract

  152. Replacement of cardiac valves in children. J Pediatr. 1972 Jun; 80(6):980-7. View Replacement of cardiac valves in children. Abstract

  153. Mexed-type total anomalous pulmonary venous drainage. Report of a successful surgical correction and review of the literature. J Thorac Cardiovasc Surg. 1972 Jan; 63(1):164-70. View Mexed-type total anomalous pulmonary venous drainage. Report of a successful surgical correction and review of the literature. Abstract

Department of Surgery | Education

Medical School

The Ohio State University School of Medicine

2006, Columbus, OH

Internship

General Surgery

Indiana University School of Medicine

2007, Indianapolis, IN

Residency

Surgery

Indiana University School of Medicine

2012, Indianapolis, IN

Fellowship

Pediatric General Surgery

Boston Children's Hospital

2015, Boston, MA

Department of Surgery | Publications

Department of Surgery | Education

Medical School

Harvard Medical School

1975, Boston, MA

Internship

Massachusetts General Hospital

1976, Boston, MA

Residency

Surgery

Massachusetts General Hospital

1983, Boston, MA

Fellowship

Pediatric Surgery

Boston Children's Hospital

1985, Boston, MA

Fellowship

Surgical Oncology

Surgery Branch-NCI

1980, Bethesda, MD

Department of Surgery | Publications

Department of Surgery | Education

Undergraduate School

University of California, Irvine

Irvine, CA

Medical School

University of California, San Francisco

San Francisco, CA

Internship

General Surgery

Stanford University

Palo Alto, CA

Residency

General Surgery

Stanford University Hospital and Clinics

Palo Alto, CA

Fellowship

Pediatric Surgery

Cincinnati Children's Hospital

Cincinnati, OH

Fellowship

Research

Stanford University Department of Health, Research & Policy

Palo Alto, CA

Department of Surgery | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services